Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Cytochrome P450 2B6 Inhibitors [MoA]: Side Effects & Safety Data for 7 Drugs

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Cytochrome P450 2B6 Inhibitors [MoA] includes 7 drugs with a combined 36,008 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.

7
Drugs in Class
36,008
Combined Reports

All Cytochrome P450 2B6 Inhibitors [MoA] Drugs Ranked by Reports

Drug Brand Name Reports Deaths Hosp. Death Rate
CANNABIDIOL Epidiolex 18,243 1,563 5,149 8.6%
CRIZOTINIB Xalkori 9,948 3,173 2,520 31.9%
CENOBAMATE Xcopri 5,643 125 1,012 2.2%
PEXIDARTINIB Turalio 970 17 91 1.8%
VILOXAZINE QELBREE 853 9 59 1.1%
LEVOKETOCONAZOLE Recorlev 309 8 99 2.6%
TRICLABENDAZOLE EGATEN 42 0 4 N/A

Common Side Effects in Cytochrome P450 2B6 Inhibitors [MoA] Drugs

Side EffectReportsDeaths
Seizure 6,632 109
Death 3,209 3,198
Product dose omission issue 2,543 27
Off label use 2,514 307
Fatigue 2,307 66
Diarrhoea 2,217 73
Hospitalisation 2,006 42
Product use in unapproved indication 1,783 102
Somnolence 1,768 12
Nausea 1,745 98
View detailed side effects for this class → Compare drugs in this class →